GeneDx · 2 days ago
Genetic Counselor, Report Writer
GeneDx is a leader in delivering personalized health insights through genomic testing and interpretation services. The Genetic Counselor, Report Writer performs variant interpretation, writes reports, and facilitates communication among laboratory personnel, genetic counselors, and clinical staff to support precision medicine initiatives.
AnalyticsArtificial Intelligence (AI)Health CareHealth DiagnosticsMachine LearningMedicalPredictive Analytics
Responsibilities
Performs variant interpretation and writes reports
May act as subject matter expert for a group of genes, disorders, tests, and/or processes
Supports team efforts required to meet corporate and team goals and objectives
Additional responsibilities depending on needs of the team may include: Abstracts clinical information from patient records
Manages urgent or complex cases at specific steps or throughout the testing process
Prepares or provides clinical review of materials for website, marketing materials, or other projects
Assists with populating variant, gene, or disease-specific test information, report language, or other clinical information in internal databases
Performs other duties assigned in support of the team or department
Qualification
Required
Master's degree from an accredited genetic counseling program
Certification by American Board of Genetic Counseling (ABGC) or equivalent
Genetic counseling licensure in the state where the employee works, if applicable
Candidates are required to submit a cover letter with their resume
Preferred
Clinical and/or laboratory experience is preferred
Prior clinical or laboratory experience preferred but not required
Benefits
Paid Time Off (PTO)
Health, Dental, Vision and Life insurance
401k Retirement Savings Plan
Employee Discounts
Voluntary benefits
Company
GeneDx
GeneDx uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.
Funding
Current Stage
Public CompanyTotal Funding
$941MKey Investors
BlackRock Innovation Capital
2023-01-26Post Ipo Equity· $150M
2023-01-10IPO
2022-01-18Post Ipo Equity· $200M
Recent News
2026-01-09
Company data provided by crunchbase